Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Creemers

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Acta Oncologica (Stockholm, Sweden)|September 2, 2016
Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancerLieke G E M Razenberg, Geert-Jan Creemers, Laurens V Beerepoot, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2016
Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based studyLieke G E M Razenberg, Valery E P P Lemmens, Victor J Verwaal, et al.
Clinical Colorectal Cancer|July 5, 2015
The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based StudyLieke G E M Razenberg, Yvette R B M van Gestel, Valery E P P Lemmens, et al.
BMC Cancer|July 11, 2006
Clinical management of women with metastatic breast cancer: a descriptive study according to age groupKlaartje Manders, Lonneke V van de Poll-Franse, Geert-Jan Creemers, et al.
Acta Oncologica (Stockholm, Sweden)|November 13, 2015
Does long-term survival exist in pancreatic adenocarcinoma?Myrte Zijlstra, Nienke Bernards, Ignace H J T de Hingh, et al.
Annals of Surgical Oncology|April 5, 2008
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancerRaphaëla C Dresen, Marleen J Gosens, Hendrik Martijn, et al.
Journal of Geriatric Oncology|September 24, 2016
The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancerLieke G E M Razenberg, Felice N van Erning, Hans F M Pruijt, et al.
The Breast Journal|May 14, 2013
Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the NetherlandsMyrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, Geert-Jan Creemers, et al.
International Journal of Cancer|July 25, 2019
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marije Slingerland, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancerMerel J M van Velzen, Marieke Pape, Willemieke P M Dijksterhuis, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Acta Oncologica (Stockholm, Sweden)|September 2, 2016
Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancerLieke G E M Razenberg, Geert-Jan Creemers, Laurens V Beerepoot, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2016
Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based studyLieke G E M Razenberg, Valery E P P Lemmens, Victor J Verwaal, et al.
Clinical Colorectal Cancer|July 5, 2015
The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based StudyLieke G E M Razenberg, Yvette R B M van Gestel, Valery E P P Lemmens, et al.
BMC Cancer|July 11, 2006
Clinical management of women with metastatic breast cancer: a descriptive study according to age groupKlaartje Manders, Lonneke V van de Poll-Franse, Geert-Jan Creemers, et al.
Acta Oncologica (Stockholm, Sweden)|November 13, 2015
Does long-term survival exist in pancreatic adenocarcinoma?Myrte Zijlstra, Nienke Bernards, Ignace H J T de Hingh, et al.
Annals of Surgical Oncology|April 5, 2008
Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancerRaphaëla C Dresen, Marleen J Gosens, Hendrik Martijn, et al.
Journal of Geriatric Oncology|September 24, 2016
The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancerLieke G E M Razenberg, Felice N van Erning, Hans F M Pruijt, et al.
The Breast Journal|May 14, 2013
Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the NetherlandsMyrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, Geert-Jan Creemers, et al.
International Journal of Cancer|July 25, 2019
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Marije Slingerland, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancerMerel J M van Velzen, Marieke Pape, Willemieke P M Dijksterhuis, et al.
Pageof 10